Share

    


Home / Search Results

Search Results

You searched for:

The increase in incidents of cardiotoxicity due to a number of cancer treatment modalities necessitates the need for cardio-oncology.
ACCC has launched Transforming Complex to Clear—a precision medicine campaign that has developed a range of tools and resources to help bring clarity to complex patient care decisions. Designed for multidisciplinary cancer teams, learn more about how these resources can enable clinicians to make educated and confident decisions.
Learn the 10 feasible and impactful “how-tos” Summit participants identified within three domains—care coordination and communication, clinical trials, and acknowledging and mitigating implicit bias.
Regardless of the reason, the ability to bill for discontinued services will depend on why the service had to be stopped and how it was addressed.
An expert ACCC Steering Committee shares 32 informed treatment and care delivery recommendations for the ideal care of patients with non-small cell lung cancer.
In addition to the global pandemic, ongoing lawsuits from referenced biologics' manufacturers suing biosimilar manufacturers are having a negative impact on the development and approval of new biosimilars.
This ACCC education program shares key highlights from a national survey of thoracic surgeons, radiation oncologists, and medical oncologists on the barriers that exist in the ideal management of patients with NSCLC.
The complexity of head and neck cancer management demands greater attention in order to provide high-quality care. UC San Diego Moores Cancer Center developed a well-defined care pathway to enable predictability and consistency in both care delivery and cost.
Though the incidence of AIDS-defining cancers has decreased with the use of antiretroviral therapy, numerous studies suggest that non-AIDS-defining cancers (cancers not previously associated with HIV and AIDS) appear to be increasing in incidence.
ASCO 2018 offered a wealth of new data that will continue to transform clinical practice and cancer program development. Most important, implementation of the scientifi c advances we learned at ASCO 2018 will improve the length and quality of life of our cancer patients.
ASCO 2017 was filled with new information and long lines as 39,000 oncologists worldwide came together to hear the latest advances in cancer care.
First announced in December 2011, Choosing Wisely is part of a multi-year effort led by the ABIM (American Board of Internal Medicine) Foundation to support and engage physicians in being better stewards of healthcare resources.